IgE-mediated asthma: New revelations and future insights

Ratko Djukanovic; Nicola Hanania; William Busse; David Price

doi:10.1016/j.rmed.2015.10.013

IgE-mediated asthma: New revelations and future insights

Respir Med. 2016 Mar:112:128-9. doi: 10.1016/j.rmed.2015.10.013. Epub 2015 Oct 30.

Authors

Ratko Djukanovic¹, Nicola Hanania², William Busse³, David Price⁴

Affiliations

¹ University of Southampton, Southampton, UK. Electronic address: R.Djukanovic@soton.ac.uk.
² Asthma Clinical Research Center, Houston, TX, USA.
³ University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
⁴ University of Aberdeen, Aberdeen, UK.

PMID: 26577335
DOI: 10.1016/j.rmed.2015.10.013

Abstract

The central role of IgE in the pathogenesis of allergic asthma has been well established; recent research has brought to light further interesting findings regarding the effects of IgE and anti-IgE therapy. This symposium explored these recent revelations and provided new insights into the importance of IgE in allergic asthma.

Keywords: Anti-IgE therapy; Asthma; IgE.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Asthmatic Agents / therapeutic use*
Asthma / drug therapy*
Asthma / immunology
Congresses as Topic
Humans
Immunoglobulin E / immunology*
Omalizumab / therapeutic use*

Substances

Anti-Asthmatic Agents
Omalizumab
Immunoglobulin E